The Gladstone Foundation is a nonprofit organization that provides financial and advisory support to Gladstone Institutes. Established in 2011, this volunteer organization is composed of dedicated leaders who understand that the search for global cures must begin with deep biological knowledge and research.

Gladstone Foundation Board of Directors

Bill Younger

William H. Younger, Jr.
Retired Managing Director
Sutter Hill Ventures

Stasia Obremskey

Vice Chair
Stasia A. Obremskey
Managing Director
Rhia Ventures 

Board Members

Chris Boskin
Media Consultant

Fred Craves
Founder and Managing Director 
Bay City Capital

Marianne De Backer, PhD, MBA
CEO and Director
Vir Biotechnology, Inc.

Paul C. Edwards
Edwards Partners

Sakurako D. Fisher
Former President
San Francisco Symphony

Tom Furst
Retired CFO
SRI International

Linda Grais, MD, JD
Former President and CEO
Ocera Therapeutics

Erin Hoffmann
President and Co-Founder
Additional Ventures

Perry Karsen
Former CEO
Celgene Cellular Therapeutics
EVP and Chief Operations Officer
Celgene Corporation

Li Lu
Founder and Chairman
Himalaya Capital

Diksha Makan
Senior Vice President of Technology Strategy
ICONIQ Capital

Gary Morgenthaler
Morgenthaler Ventures

Deep V. Nishar
Managing Director
General Catalyst

Christopher R. Redlich, Jr.

Steve Richardson
Consultant, Executive Management
Alexandria Real Estate Equities, Inc.

Douglas G. Scrivner
Retired General Counsel

Deepak Srivastava, MD
Gladstone Institutes
Roddenberry Stem Cell Center

James B. Tananbaum, MD
Founder, CEO, and Managing Director
Foresite Capital Management

R. Sanders Williams, MD
President Emeritus
Gladstone Institutes

Sharon Winslow

Board Officers

Chris Nicholson

Michelle Sibly

Robert Wicks